Comparison window: 13 Jan 2016 → 8 Sept 2026 (max: from the most recent launch) · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared
Report produced on 10 September 2026 · data as of the dates shown per section Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat Public methodology: rebalix.com/en/methodology
Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.
RebalixLU1221102491 vs LU0838782315 · report of 10 September 2026
The funds at a glance
From official issuer documents and the ESMA register
From 13 Jan 2016 to 8 Sept 2026 · base 100 · ECB rates, dividends reinvested where declared
In euro (nominal)
In today’s purchasing power (net of Italy inflation)
Same scale in both panels: the gap between endpoints is Italian inflation over the period (Eurostat). Volatility stays nominal, as everywhere on the site.
How far they fell — drawdown from peak (nominal)
In euro · distance from the previous peak, day by day, on NAV: for distributing classes it includes ex-dividend drops (slightly deeper than total return)
Filled area: LU1221102491; thin lines: the other funds.
The worst episode, fund by fund
Fund
Max drawdown
Trough
Recovery time
Underwater
LU1221102491
−38.1%
18 Mar 2020
334 days
362 days · back to break-even on 15 Feb 2021
LU0838782315
−41.4%
18 Mar 2020
379 days
1,164 days · back to break-even on 01 Apr 2021
"Recovery time" = the climb only: trough to break-even (0%). "Underwater" = decline + recovery: peak to break-even.
Drawdown net of Italy inflation
Same curve in purchasing-power terms: as on the site, drawdown follows the real view (volatility stays nominal, per methodology)
In real terms declines are deeper and recoveries slower. Monthly price index (Eurostat), held at the last published value.
Rebalix · LU1221102491 vs LU0838782315section 2 of 4
RebalixLU1221102491 vs LU0838782315 · report of 10 September 2026
36 common holdings · ticker match on full official portfolios
How the shared part is computed: for each security held by both funds, only the SMALLER of the two weights counts — a stock at 5% in one fund and 1% in the other overlaps by 1%, not 5%. Summed over all 36 common holdings this gives 100.0%: buying both funds, roughly this share of your money buys the same stocks twice. Matching is by company (one issuer does not publish security identifiers): identical holdings written differently may be missed, so the real overlap can be higher than shown.
Rebalix · LU1221102491 vs LU0838782315section 3 of 4
RebalixLU1221102491 vs LU0838782315 · report of 10 September 2026
Full comparison table
"—" = not published by the source, never estimated
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~121 euro LU1221102491 · ~57 euro LU0838782315. Broker costs not included.
Disclaimer
This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.
Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.
Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.
Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.
Rebalix · LU1221102491 vs LU0838782315section 4 of 4